QIAseq Multimodal Pan-Cancer Panel

The only one-day, low-input sample to sequencing workflow for simultaneous and comprehensive genomic profiling of DNA variants, RNA fusions and assessing TMB/MSI in solid tumors and heme malignancies

QIAseq enrichment technology is the basis for Multimodal's uniform and complete coverage of targets, including complex genes like CEPBA, and confident detection of known and novel fusions
Pre-optimized protocol to go from total nucleic acid extraction to preparation of UMI-containing, unique dual-indexed, NGS-ready libraries using a single-day workflow to enhance sensitivity, improve error correction and reduce index hopping
Pre-configured automation-compatible workflow solution with secondary analysis and variant interpretation for rapid onboarding, faster turnaround time and improved scalability